-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $100

Benzinga·02/11/2026 17:05:45
Listen to the news
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $98 to $100.